The "Research Advancing to Market Production for Innovators Act" seeks to significantly improve the commercialization outcomes of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. It amends the Small Business Act to require that peer reviews for these programs include an assessment of the likelihood of commercialization , alongside scientific and technical merit, and mandates the inclusion of at least one reviewer with commercialization expertise. This change aims to ensure that innovative research has a clearer path to market. The bill extends the authority for Federal agencies to make direct Phase II awards, known as "Phase Flexibility," for fiscal years 2025 through 2027, with specific funding limitations for most agencies, but a higher limit for the National Institutes of Health and no limit for the Department of Defense. Furthermore, each Federal agency participating in SBIR or STTR must designate a Technology Commercialization Official . This official will guide awardees, advocate for promising technologies, and coordinate with other agencies to identify commercialization pathways, ensuring dedicated support for transitioning research into viable products. Significant improvements are made to Technical and Business Assistance (TABA) , allowing award recipients to select assistance providers and utilize funds for hiring staff or training. The bill also expands TABA services to include cybersecurity assistance and increases the maximum TABA funding to $6,500 for Phase I and $50,000 for Phase II projects. These changes provide small businesses with greater flexibility and resources to address critical business and technical needs. To further support commercialization, the legislation requires Federal agencies with Innovation Corps (I-Corps) programs to offer participation options to SBIR/STTR awardees, allowing them to use TABA funds for this training. It also mandates an annual Commercialization Impact Assessment , which will measure various metrics for high-volume Phase II awardees, including total Federal awards, revenue, investments, patents, and employee growth, providing a comprehensive overview of commercial success. Finally, the bill establishes a prioritized patent examination program for SBIR and STTR recipients through an interagency agreement between the Small Business Administration and the United States Patent and Trademark Office (USPTO). This initiative, coupled with coordinated outreach regarding USPTO's Pro Se Assistance Program and scam prevention services, aims to streamline intellectual property protection for small businesses developing federally funded innovations.